Uniphar

H1 2021 trading update: firing on all cylinders

  • Sectors : Pharma and healthcare
  • Companies : Uniphar

Ratings and price correct at time of issue.

  • Uniphar

    Closing Price: 370c

  • RATING 27/08/19

  • PREVIOUS RATING N/A

DAVY VIEW

Uniphar has delivered a strong first half, with group organic gross profit growth of 11%. Even adjusting for an estimated 2-3%-point benefit from weak COVID ‘comps’ last year, this is still an exceptionally strong result – supported by delivery across all three divisions. We have left our full year EPS forecasts unchanged for the time being, based on guidance, but note that management has built a strong track record since IPO of outperforming expectations. Detailed H1 2021 results are expected on September 1st. We reiterate our ‘Outperform’ rating.

Download full report with analyst certification and important disclosures

Jul 27 2021, 07:10 IST/BST

Download